Karen AIACH-PIGNET
“Rare diseases: The close and essential collaboration between start-ups and academia”
Biopharmaceutical Director, Founder of Lysogene, CEO Genespire
Pasteur-Weizmann/Servier Prize
Since 2003 L’Institut Servier has partnered with the Institut Pasteur/Weizmann Institute of Sciences Council to award the Pasteur-Weizmann/Servier International Prize (250,000 euros) to a researcher, a medical doctor or a scientist for major contribution to a biomedical discovery determining a major therapeutic application.
The objective of the prize is to promote and encourage fundamental research, in particular the transition from laboratory research to medical therapy.
The Scientific Committee of the Prize is made up of scientists from the Pasteur Weizmann Council, scientists from the Institut Servier and 3 international experts in rare genetic diseases. After reviewing the applications received, the Prize’s Scientific Committee will elect the winner.
The 8th Pasteur-Weizmann/Servier Prize was officially award to the winner in 2024 at a symposium dedicated to rare childhood diseases on 9 January 2025.
2024 Pasteur-Weizmann/Servier Prize Laureate
On January 9, 2025 at the Institut Pasteur (Paris), the Pasteur-Weizmann/Servier Prize was awarded to Professor Valérie Cormier-Daire, a paediatrician in the medical genetics department of the Hôpital Necker-Enfant-Malades and Inserm research Director of the Institut Imagine.
This international Prize, dedicated this year to rare children genetic diseases, rewards the career of this clinical researcher, devoted to the study of dysfonctional bone development and the therapeutic options that can be identified accordingly.
Colloquium of the Pasteur-Weizmann/Servier Prize 2024: “Rare childhood diseases”
The speakers of the colloquium:
Arnold MUNNICH, PhD
“What are the transfer rates from research projects to clinical trials at the Imagine Institute?”
Paediatrician and geneticist, President of the Imagine Institute
François DOS, PhD
“Retinoblastoma: a model?”
Paediatric oncologist, Institut Curie
Previous laureates
Myelin regeneration in the treatment of multiple sclerosis
Head of the University Medical Neuroscience Department of AP-HP Sorbonne University and Medical Director of the Paris Brain Institute located at the Center of the Pitié-Salpêtrière Hospital
Immuno-regulation and cancer
Director and founder of the cellular engineering center at the Memorial Sloane-Kettering Cancer Center in New York (USA).
Emerging viral pathogen
Director of the Structural Virology Unit at the Institut Pasteur Paris and member of the French Academy of Sciences.
Circulating biomarkers
Professor of pharmacology, University of Manchester.
Professor of pharmacology, University of Manchester.
